Citadel Advisors »

Synthetic Biologics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Synthetic Biologics (TOVX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Synthetic Biologics

Tip: Access up to 7 years of quarterly data

All positions including Synthetic Biologics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Synthetic Biologics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $12k 25k 0.47
2023-12-31 $25k 58k 0.43
2023-03-31 $14k 21k 0.70

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Synthetic Biologics

Vanguard Group
BlackRock
Geode Capital Management
Virtu Financial
Northern Trust
Citadel Advisors
Two Sigma Securities
Charles Schwab Investment Management
Lincoln National
SageView Advisory Group
William Blair $ Company
Iron Horse Wealth Management
IFP Advisors
Wells Fargo & Company
Tower Research Capital

View all funds holding Synthetic Biologics